Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04379700 · ClinicalTrials.gov registry record · NA

Geniculate Artery Embolization for Treatment of Osteoarthritis

A NA study of Osteoarthritis, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
38
Enrollment target
1
Study location

NCT04379700 is a NA study of Osteoarthritis that has completed, run by NYU Langone Health. The registered enrollment target is 38 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04379700, a NA study of Osteoarthritis, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target
1
Study location

Study Summary

Single-arm, single-center, no sham or placebo, prospective pilot trial designed to evaluate the feasibility and safety of transcatheter arterial embolization in patients with mild to moderate radiographic knee OA. Eligible participants will receive geniculate artery embolization using Embozene™ Color-Advanced Microspheres. Patients will be followed up for a total of 12 months.

Conditions Studied

Interventions

  • PROCEDURE Transcatheter arterial embolization
  • DEVICE Embozene™ Microspheres

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2020-12-01
Est. Completion 2025-03-12
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT04379700

The ClinicalTrials.gov registry entry for NCT04379700 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (95% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Transcatheter arterial embolization is the first listed.

NCT04379700 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT04379700 about?

NCT04379700 is a clinical study titled "Geniculate Artery Embolization for Treatment of Osteoarthritis". Single-arm, single-center, no sham or placebo, prospective pilot trial designed to evaluate the feasibility and safety of transcatheter arterial embolization in patients with mild to moderate radiographic knee OA. Eligible participants will receive geniculate artery embolization using Embozene™ Colo...

What is the current status of trial NCT04379700?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2020-12-01. Estimated completion is 2025-03-12.

What conditions does trial NCT04379700 study?

This clinical trial studies the following conditions: Osteoarthritis.

What interventions are being tested in trial NCT04379700?

The interventions under investigation include: Transcatheter arterial embolization (PROCEDURE), Embozene™ Microspheres (DEVICE).

Who is sponsoring clinical trial NCT04379700?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04379700 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.